Roth Conference Archives - Page 35 of 117

MondayMar 18, 2019 4:30 pm

Manitex International Inc. (NASDAQ: MNTX) Attends 31st Annual ROTH Conference

Manitex International (NASDAQ: MNTX) is a global provider of highly engineered mobile cranes (truck mounted straight-mast and knuckle boom cranes, industrial cranes, rough terrain cranes, and railroad cranes), truck-mounted aerial work platforms and specialized industrial equipment. The company’s products, manufactured in facilities in the USA and Europe, are targeted to selected niche markets where their unique designs and engineering excellence fill the needs of customers and provide a competitive advantage. Manitex has consistently added to its portfolio of branded products and equipment both through internal development and focused acquisitions to diversify and expand its sales and profit base. For more…

MondayMar 18, 2019 4:30 pm

MagnaChip Semiconductor Corp. (NYSE: MX) Attends 31st Annual ROTH Conference

MagnaChip Semiconductor (NYSE: MX) is a designer and manufacturer of analog and mixed-signal semiconductor platform solutions for communications, IoT, consumer, industrial and automotive applications. The company's Standard Products Group and Foundry Services Group provide a broad range of standard products and manufacturing services to customers worldwide. MagnaChip, with over 30 years of operating history, owns a portfolio of approximately 3,100 registered patents and pending applications, and has extensive engineering, design and manufacturing process expertise. For more information, visit the company's website at www.magnachip.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to…

MondayMar 18, 2019 4:30 pm

AzurRx BioPharma Inc. (NASDAQ: AZRX) Attends 31st Annual ROTH Conference

AzurRx BioPharma (NASDAQ: AZRX) is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. MS1819 recombinant lipase for exocrine pancreatic insufficiency is the company's lead development program, and additional early stage research is being conducted for the prevention of hospital-acquired infections. The company is headquartered in Brooklyn, NY, with scientific operations based in Langlade, France. For more information, visit the company's website at www.azurrx.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets,…

MondayMar 18, 2019 4:30 pm

AxoGen Inc. (NASDAQ: AXGN) Attends 31st Annual ROTH Conference

AxoGen (NASDAQ: AXGN) is focused on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. The company is helping to restore peripheral nerve function and quality of life to patients with physical damage or discontinuity to peripheral nerves by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. AxoGen's platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. AxoGen also offers AcroVal Neurosensory & Motor Testing System and AxoTouch Two-Point Discriminator, evaluation and…

MondayMar 18, 2019 4:30 pm

Avalon GloboCare Corp. (NASDAQ: AVCO) Attends 31st Annual ROTH Conference

Avalon GloboCare (NASDAQ: AVCO) is a global intelligent biotech developer and healthcare service provider dedicated to advancing cell-based technologies and therapeutics, with a focus on developing and empowering innovative and transformative cell-based technologies and their clinical applications. In addition, Avalon provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth, development, as well as competitiveness in both the domestic and global healthcare markets. Through its subsidiaries, namely GenExosome Technologies Inc. and Avactis Biosciences Inc., Avalon is establishing a leading role in the fields of exosome-based diagnostics, cellular immunotherapy (including CAR-T/CAR-NK), and regenerative medicine. For more information, visit…

MondayMar 18, 2019 4:00 pm

Asure Software Inc. (NASDAQ: ASUR) Attends 31st Annual ROTH Conference

Asure Software (NASDAQ: ASUR) offers intuitive and innovative solutions designed to help organizations of all sizes and complexities build companies of the future. The company’s cloud platforms enable more than 100,000 clients worldwide to better manage their people and space in a mobile, digital, multi-generational, and global workplace. Asure Software’s offerings include a fully-integrated HCM platform, flexible benefits and compliance administration, HR consulting, and time and labor management as well as a full suite of workspace management solutions for conference room scheduling, desk sharing programs, and real estate optimization. For more information, visit the company's website at www.asuresoftware.com. About NetworkNewsWire…

MondayMar 18, 2019 4:00 pm

Astea International Inc. (ATEA) Attends 31st Annual ROTH Conference

Astea International (OTCQB: ATEA) is a global player in field service and mobile workforce management, including the cornerstones of full-service lifecycle management: customer management, service management, asset management, forward and reverse logistics management, and mobile workforce management and optimization. Astea helps the world’s best service-driven companies generate higher profit while balancing customer satisfaction and service levels through proactive communication that creates seamless, consistent and highly personalized experience at every customer relationship touch point. Astea’s solutions unify processes, people, parts and information to focus the entire organization on the creation of sustainable value in highly competitive, global markets. For more information,…

MondayMar 18, 2019 4:00 pm

Assure Holdings Corp. (ARHH) Attends 31st Annual ROTH Conference

Assure Holdings (OTCQB: ARHH) is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. While Assure focuses primarily on supporting spinal and vascular surgeries, plans are in place to support other classes of medicine that rely on the standard of care that intraoperative neuromonitoring provides. For more information, visit the company's website at www.assureneuromonitoring.com.…

MondayMar 18, 2019 4:00 pm

MAG SILVER Corp. (NYSE American: MAG) Attends 31st Annual ROTH Conference

MAG SILVER (NYSE American: MAG) is a Canadian exploration and development company focused on becoming a top-tier primary silver mining company by exploring and advancing high-grade, district scale, silver-dominant projects in the Americas. The company’s principal focus and asset is the Juanicipio Property (44%), being developed in partnership with Fresnillo Plc (56%) and is in the Fresnillo Silver District in Mexico, the world's premier silver mining camp. MAG SILVER is presently developing the underground infrastructure on the property, under the operational expertise of Fresnillo plc, to support an expected 4,000 tons per day mining operation. For more information, visit the…

MondayMar 18, 2019 4:00 pm

Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Attends 31st Annual ROTH Conference

Madrigal Pharmaceuticals (NASDAQ: MDGL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need. Madrigal’s lead candidate, MGL-3196, is a first-in-class, orally administered, small-molecule, liver-directed, thyroid hormone receptor (THR) β-selective agonist that is currently in phase 2 development for non-alcoholic steatohepatitis (NASH) and heterozygous familial hypercholesterolemia (HeFH). For more information, visit the company's website at www.madrigalpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides…